Home / Industry / Pharmaceuticals & Biotechnology / Cancer Gene Therapy Market

Cancer Gene Therapy Market

Cancer Gene Therapy Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: May 2026 | Format: | No. of Pages: 192

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Customisation / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Cancer Gene Therapy Market

The Cancer Gene Therapy Market is valued at USD 4.6 Billion in 2026.

The Cancer Gene Therapy Market is projected to grow at a 10% CAGR through 2033.

The Cancer Gene Therapy Market growth is driven by the rising prevalence of cancer, increasing R&D investments in gene therapies, and improving regulatory support for advanced cancer treatments.

North America is the dominant region in the Cancer Gene Therapy Market.

Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb Company, Pfizer Inc., and Johnson & Johnson are some leading industry players in the Cancer Gene Therapy Market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services